Breakout Session 2

Business and National Security
Michael Sonnenfeldt, Chairman, MUUS & Company
Mary Boies, Partner, Boies & McInnis, LLP
Nigel Fisher, Executive Director, United Nations Office for Project Services (UNOPS)
Larry Smith, Chief Operating Officer, Business Executives for National Security (BENS)

Has the art and science of running a business been altered by September 11th and by the new security constraints implemented soon after? If so, how should a prudent business leader adapt to those changes? Do corporations have more responsibility to safeguard the public interest? How can interested business leaders help improve global security? This panel brings together experts with backgrounds in finance, law, government, and post-conflict reconstruction to address these timely questions.

Issuing Debt for Non-Profits
Bruce M. Kahn, Financial Consultant, Smith Barney
Diane F. Viacava, Vice President/Senior Credit Officer, Moody’s Investors Services
John H. Augustine, Managing Director, Lehman Brothers
Sarah Gillman, Vice President of Budget and Financial Planning, Wildlife Conservation Society

What is the process that non-profit institutions go through to issue debt? Who are the key players, and what are their roles? What is the nature of the relationship and the potential conflicts between non-profit, ratings agency, and investment bank? This panel will explore the reasons that non-profits issue debt, the ratings process, and the role of the investment banker in the issuance of debt.

Pharma and Biotech: Shaping the Delivery of Health Care in the United States
Dr. Francoise Simon, Professor, Columbia Business School
Chris Garabedian, Vice President, Marketing, Gilead Sciences
Dolly Judge, Senior Director, Federal Relations, Pfizer
Jayson Slotnik, JD, MPH, Director of Medicare Reimbursement and Economic Policy, Biotechnology Industry Organization (BIO)
Cynthia Smith, Senior Director of Public Policy, Merck and Company, Inc.

The United States Health Care Industry is facing a crisis. Health care costs continue to rise, and access to care is an increasingly serious problem as more and more patients go without insurance. Pharmaceutical and Biotechnology companies actively work to increase access to health care for people in need of assistance. In addition, many companies have played a major role in shaping health care policy, most recently with President Bush’s signing of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. This panel will explore the improvements that have been realized, as well as the challenges and opportunities that exist for Pharma and Biotech companies to help improve access to quality health care in the United States.

Can Confidence in Corporate America Be Restored?
Raymond D. Horton, Frank R. Lautenberg Professor of Ethics and Corporate Governance and Director of the Social Enterprise Program, Columbia Business School
Carol Bowie, Director of Governance Research, Investor Responsibility Research Center
Michael I. Garland, Corporate Transactions Coordinator, AFL-CIO Office of Investment
Henry B. Schacht, Managing Director and Senior Advisor, Warburg Pincus; Senior Advisor and Past Chairman and CEO of Lucent Technologies

In the past few years, confidence in American business has been shaken by a wave of scandals that have imposed enormous economic and social costs. This panel will discuss whether recent reforms in corporate governance will address the problem of corporate malfeasance and help restore confidence in the American business system.

Mainstreaming Corporate Social Responsibility and Sustainability: Opportunities and Risks
Michael Gresty, President and co-founder, Kinetix
Marcus Chung, Manager, Public Affairs, Gap Inc.
Krista Pilot, Director of Corporate Giving and Community Relations, United Technologies Corporation
Robin Smith Luhning, Manager, Corporate Social Responsibility, Colgate-Palmolive Company

How is CSR/sustainability integration occurring today? This session will highlight some of the drivers for CSR/sustainability and current initiatives in each panelist’s company and assess the benefits and challenges they face in designing and implementing those initiatives.

The Business Case for Wind: The Economics of an Emerging Energy Industry
Edwin F. Feo, Partner, Milbank, Tweed, Hadley & McCloy LLP
Peter Mandelstam, President, Arcadia Windpower Ltd.
Michael Payne, Senior Vice President Northern Europe, Shell Wind
Mark Tholke, Lead Development Associate, Americas Development, GE Wind Energy

Wind, a clean and entirely renewable source of energy, is the fastest growing source of electricity generation in the world today. The cost of producing electricity from wind has dropped dramatically in the last two decades, from 30 cents per kWh to less than five cents per kWh. With technological advances and a free fuel source, wind is poised to become a major energy source for the future, yet many constraints on wind energy development still remain in the U.S. This panel will discuss the changing economics of the wind industry, including how wind's generation cost and market potential compare with that of conventional energy and other renewables. Panelists will also discuss the regulatory environment in the U.S and Europe.

Creative Solutions to Solid Waste Management
Scott Kaufman, Junior Research Associate, Columbia University Earth Engineering Center
Janice Canterbury, Environmental Scientist, US EPA Office of Solid Waste
Gil Friend, President and CEO, Natural Logic, Inc.
James Taylor, Jr., Chairman, Taylor Recycling Facility, LLC

Is it possible to become a zero-waste, “closed-loop” society, and what role does business play in encouraging these positive changes? As a consumption-driven society, landfills are quickly filling up. Recycling plays a crucial part in diverting a portion of our waste stream from landfills. This panel will explore the newest developments in materials recycling, with a focus on effective ways of turning waste into revenue-generating materials using the latest recycling and gasification technologies.

Case Study: HIV/AIDS and Corporate Strategy
Sabine Durier, Program Leader, IFC Against AIDS

Ms. Durier will give an overview of the business case to integrate HIV/AIDS into corporate strategy. She will then guide session participants through a case discussion, which examines a specific company's risks and vulnerabilities with regard to HIV/AIDS and how the company dealt with the situation. Download presentation (.ppt) here.

Microfinance: Which Strategies Work?
William Duggan, Professor, Columbia Business School
Christina Barrineau, Chief Technical Advisor, United Nations Capital Development Fund
Sam Daley-Harris, Director, Microcredit Summit Campaign
Maggie Neilson, Vice President of Strategic Development, Unitus
David Satterthwaite, President and CEO, Prisma MicroFinance
Warner Woodworth, Professor, Brigham Young University

Microfinance has attracted global attention as a powerful tool to fight poverty. When poor people have access to financial services, they can earn more and invest in better nutrition, housing, health, and education. This panel deals with fundamental microfinance issues, such as geographic concentration, the debate over microfinance and sustainability, and the move towards a commercial financial institution model.

Generation AND: Money and Meaning
Dr. Mark S. Albion, Founder, You & Company

How do you do what you love AND not starve to death?
How do you move your career ahead AND not leave your family behind?
How do you work AND play, make a living AND enjoy life?
Mark will answer your questions and speak about his personal journey - and those of his friends - using them to illustrate what he calls "lifelines". These lifelines are intended to inspire, challenge and instruct you on the lifelong process of aligning your work with your values, of creating a life of social contribution and personal betterment.

Are you interested in social entrepreneurship in the areas of Economic & Community Development, Education & Arts, Energy & Environment or Health? If so, we welcome you to participate as an audience member in one of the New Venture Labs. Each lab will include a panel comprised of entrepreneurs, academics and/or practitioners in the fields of entrepreneurship and social entrepreneurship, and a student entrepreneur who will present his/her own business plan. This is a participatory session; all audience members are asked to provide written feedback to the student presenters. This session will help entrepreneurs prepare for business plan competitions, including the Global Social Venture Competition.
For further information, please contact Sachin Sarnobat.

New Venture Lab: Economic & Community Development
Ventures that support sustainable economic development.
Examples:
o Prisma Microfinance – Lending and credit services to clients in Central America considered unbankable by conventional financial institutions.
o The Maine Highlands Guild – Promotes and sells local art, crafts, and traditional products for sustainable community and economic development.

New Venture Lab: Education & Arts
Ventures that improve on existing educational programs, develop innovative educational models, or provide cultural or media-related opportunities for their target population.
Examples:
o Bronx Charter School for the Arts – A non-profit public charter elementary school in the Hunts Point section of the South Bronx founded on the principle that arts education is a catalyst for academic and social success.
o Leapfrog (formerly Wise Toad) – Interactive, multi-sensory learning materials for adults to acquire basic literacy.

New Venture Lab: Energy & Environment
Ventures emphasizing conservation of natural resources through projects such as renewable energy sources or promotion of environmentally sustainable practices.
Examples:
o Sea Power & Associates – Harnesses ocean wave power to produce electricity for coastal communities in the Pacific.
o Wilson Turbo Power Inc. – Next-generation microturbines that will be the first distributed power generation products to have both efficiencies and costs comparable to centralized power generation.

New Venture Lab: Health
Ventures that aim to improve the health and well-being of the target population.
Examples:
o EasyDiabetes – Built an Internet-based support system that will, among other things, allow patients to hook up their blood sugar monitor to the computer and have the results sent to a physician in an easily readable form.
o Aprotea BioChips – Develops biochips to enhance drug discovery.